Informazioni sul prodotto
- (2S)-3-[4-(Acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
- (2R)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
- (2S)-3-(4-Acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
- GTx 007
- Propanamide, 3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-, (2S)-
- S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
- S4
- Sarm S-4
Andarine is a selective androgen receptor modulator (SARM) that is currently being studied as a potential treatment for prostate cancer. Andarine binds to the AR with high affinity and specificity, and has been shown to inhibit the growth of prostate cancer cells in vitro. It also inhibits the production of prostate-specific antigen (PSA) in human prostate cancer cells, which may be related to its ability to inhibit the activity of protein kinase C (PKC). In addition, Andarine has been shown to have anti-estrogenic effects in breast cancer cells by inhibiting 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2), a key enzyme in estrogen synthesis. Andarine has not yet been tested on humans, but has been found to cause few side effects in animals.
Proprietà chimiche
Richiesta tecnica su: 3D-FA17901 Andarine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.